New long-term data from two clinical trials of a gene therapy for Leber hereditary optic neuropathy (LHON) have shown that the treatment can lead to clinically meaningful improvements in visual function, researchers reported at NANOS 2020.
News News Daily digests from key neurology conferences, written by on-site medical journalists.